ScholarIQanswers from OpenAlex

Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway

PaperCitations, authors & open-access status

Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway have?

ScholarIQcitation count

Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway has 133 citations in the OpenAlex counts ScholarIQ stores.

When was Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway published?

ScholarIQyear

Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway has 2015 year in the ScholarIQ index.

What is the open-access status of Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway?

ScholarIQoa status

Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway has gold oa status in the ScholarIQ index.

What is the DOI of Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway?

ScholarIQdoi

The DOI for Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway is on the source record.

What is the PMID of Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway?

ScholarIQpmid

The PMID for Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway is on the source record.

What is the OpenAlex record for Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway?

ScholarIQopenalex

The OpenAlex for Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial